In 2014, Canada passed C-17, the Protecting Canadians from Unsafe Drugs Act, also known as Vanessa’s Law, which empowers Health Canada to develop regulations governing mandatory reporting of SADRs and MDIs to the federal government. HealthCareCAN regularly produces updates and issue briefs to members on emergent health policy issues. They have developed a document providing updates and implications, which is available to N2 members. Click here to read the document.
To enable and enhance clinical research capability and capacity in Canada.